drugset / Trial / NCT07559331
High-Dose Dexamethasone Combined With Orelabrutinib Versus High-Dose Dexamethasone Combined With Placebo in Adult Patients With Newly Diagnosed Primary Immune Thrombocytopenia
RandomizedParallel-groupDouble-blindTreatment
Summary
This is a randomized controlled study of high-dose Dexamethasone combined with Orelabrutinib versus high-dose Dexamethasone combined with placebo in adult patients with newly diagnosed Primary Immune Thrombocytopenia.
Timeline
- Start
- 2026-04-08
- Primary completion
- 2027-04-08
- Completion
- 2028-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Orelabrutinib | Small molecule | 50 mg | — |
| Background | Dexamethasone | Small molecule | 40 mg | — |